Mon, November 5, 2018

Matthew Harrison Maintained (BLUE) at Hold with Decreased Target to $185 on, Nov 5th, 2018

Matthew Harrison of Morgan Stanley, Maintained "bluebird bio, Inc." (BLUE) at Hold with Decreased Target from $186 to $185 on, Nov 5th, 2018.

Matthew, nor any peers, have made any analyst calls on BLUE in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30